Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LARP1 pseudogene 1 (LARP1P1), also known as dJ221C16.7, is a pseudogene corresponding to the functional LARP1 gene. Unlike LARP1, which is an RNA-binding protein involved in post-transcriptional gene regulation downstream of mTORC1 and functions in translation control, LARP1P1 does not encode a functional protein and is not implicated in any known biological processes, disease mechanisms, or as a therapeutic target. Pseudogenes generally lack protein-coding potential and are not considered viable drug targets[3]. LARP1P1 is not a molecular target (e.g., receptor, enzyme, transporter) but a non-functional pseudogene, and is not itself a therapeutic or diagnostic target[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LARP1 pseudogene 1 (LARP1P1).